Press
David P. King joins Truvianās Advisory Board
Truvian today announced the appointmentĀ of David P. King to its Advisory Board. King brings decades of diagnostics and business experience with a distinguished track record of advancing innovation and shaping corporate strategy.
Truvian Health Appoints Dr. Tina Nova to its Board of Directors
Truvian announced the appointment of Tina S. Nova, Ph.D., to its Board of Directors. Dr. Nova has more than two decades of experience serving as an executive and board member in some of the most storied franchises in diagnostics and biotech.
Independent Study Highlights Robustness and Ease-of-Use of Truvianās Blood Testing Platform in a Real-World Clinical Setting
Researchers from University of California San Diego School of Medicine will be providing the latest evidence from a recent evaluation of Truvianās multi-modal blood testing platform at the ADLM meeting in Chicago.
Truvian Health raises $74M to bring blood testing to anyone, anywhere
Use of proceeds in part to secure US Food and Drug Administration (FDA) clearance for its blood testing platform.
Truvian Health Presents Multi-Site Clinical Study Data on Its Benchtop Blood Testing Platform to Enable Central Laboratory Quality Results Anywhere
Data presented at 2023 American Association for Clinical Chemistry Annual Scientific Meeting
Truvian Health to Present Performance of Blood Testing Solution from Recent Multisite Clinical Study at the American Association of Clinical Chemistry Annual Scientific Meeting
Ongoing studies continue to evaluate the performance of the Truvian Platform compared to central lab testing
Truvian Sciences Raises More Than $105 Million in Oversubscribed Series C Financing
Funding Will Accelerate FDA Submission and Commercialization of Automated Benchtop Blood Testing System
Truvian Sciences Names Jean-Pierre Millon to its Board of Directors
Decorated Healthcare Executive and Current CVS Health Director Brings Deep Expertise to Burgeoning Blood Testing Company
Truvian Sciences Debuts New Headquarters in San Diego
Company Moves to New World-Class Laboratory and Office Space on Heels of $27.1 Million Series B Financing
Truvian Sciences Accelerates Plans with $27.1 Million Series B Financing to Develop an Automated Benchtop Blood Testing System for Rapid Assessment of a Full Suite of Health Tests
Company Aims to Make Routine Health Testing Convenient, Affordable and Actionable